Archon X PRIZE for Genomics would like to thank the following donors for their support:

Dr. Stewart and Marilyn Blusson
Bita Daryabari and Omid Kordestani
J. Craig Venter Institute

To make a donation in support of the Archon X PRIZE for Genomics click here

Supporting Organizations:

The Accelerated Cure Project is creating a large-scale bio-repository to be used to determine the causes of MS. This open-access resource contains blood, epidemiological, and clinical data from people with MS and matched controls. In exchange for access, researchers are required to return the per-sample data they generate to the repository to be shared with other researchers. For more information, visit www.acceleratedcure.org.

The Alpha-1 Foundation is a not-for-profit Florida corporation founded in 1995 by John W. Walsh, Susan Stanley and Sandy Lindsey, three individuals diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1). The Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1. The majority of the Board of Directors are either diagnosed with Alpha-1 or have a family member diagnosed with Alpha-1. For more information, visit www.alphaone.org.

FasterCures is an "action tank" committed to building faster tracks to find tomorrow's cures today. Our mission is to clear the path between an idea for treatment and getting a treatment to the patient. For more information, visit www.fastercures.org.

FRAXA’smission is to accelerate progress toward effective treatments and ultimately a cure for Fragile X, by directly funding the most promising research. Fragile X is the most common inherited cause of mental impairment and the most common identified cause of autism. FRAXA was founded in 1994 by three parents of children with Fragile X and continues to be run by parents to this day. For more information visit www.fraxa.org.

Genetic Alliance increases the capacity of genetic advocacy organizations to achieve their missions and leverages the voices of millions of individuals and families living with genetic conditions. With a 20-year history as a 501(c)(3) not-for-profit organization, Genetic Alliance is dedicated to improving the quality of life for everyone living with genetic conditions. We are committed to capacity building in all communities. The technical assistance we provide to advocacy organizations results in measurable growth: increased funding for research, access to services, and support for emerging technologies. For more information, visit www.geneticalliance.org.

March of Dimes. Our mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. We carry out this mission through research, community services, education and advocacy to save babies' lives. March of Dimes researchers, volunteers, educators, outreach workers and advocates work together to give all babies a fighting chance against the threats to their health: prematurity, birth defects, low birthweight. For more information, visit www.marchofdimes.com.

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research. Established in 1948, the National Hemophilia Foundation is a non profit 501(c)3 organization with chapters throughout the country. Its programs and initiatives are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC). For more information, visit www.hemophilia.org.

The Foundation for Prader-Willi Research (FPWR) is comprised of parents, families, researchers, and others interested in addressing the issues that come with Prader-Willi Syndrome and childhood obesity. Founded in 2003 by parents of children with Prader-Willi syndrome (PWS), the mission of FPWR is to eliminate the challenges of Prader Willi syndrome through the advancement of research. All proceeds go toward the support of Prader-Willi research. Members of FPWR believe that, through research, treatments can be found that will lessen the restrictions placed on individuals with PWS and their families. These advancements will provide those with the syndrome an opportunity to lead more independent lives. For more information, visit www.fpwr.org.

The Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research. Founded in 1993, the PCF has raised more than $260 million and provided funding for prostate cancer research to more than 1,200 researchers at 100 institutions worldwide. The PCF has a simple, yet urgent goal: to find better treatments and a cure for recurrent prostate cancer. For more information, visit www.prostatecancerfoundation.org.

Research!America is the nation's largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by more than 500 member organizations that represent the voices of more than 125 million Americans. Our public opinion polls, advocacy programs and publications reach the public and decision makers to help advance medical and health research. For more information, visit www.researchamerica.org.

The Susan G. Komen Breast Cancer Foundation was founded in 1982 on a promise made between two sisters – Susan Goodman Komen and Nancy Goodman Brinker. More than 20 years later, the Komen Foundation is a global leader in the fight against breast cancer through its support of innovative research and community-based outreach programs. Working through a network of U.S. and international Affiliates and events like the Komen Race for the Cure®, the Komen Foundation is fighting to eradicate breast cancer as a life-threatening disease by funding research grants and supporting education, screening and treatment projects in communities around the world. For more information, visit www.komen.org.

TRAC - Translating Research Across Communities, established by Paula Kim to bridge the gap between the patient and healthcare communities and those with whom they must collaborate to accelerate research and care that benefits patients. For more information, visit www.tracnetwork.org.